We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research

Product News   Jul 03, 2018

 
Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody

 
 
FURTHER INFORMATION
 
 
 

Related Product News


Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology Target

Product News

PhoreMost has identified and validated the target using its next-generation SITESEEKER® phenotypic screening technology.

READ MORE

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

Product News

The collaboration will focus on discovering ultra-rare antibodies with certain defined properties for the treatment of an array of infectious diseases.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE